Literature DB >> 33816694

Claudin-1 down-regulation in the prostate is associated with aging and increased infiltration of inflammatory cells in BPH.

Laura E Pascal1,2, Rajiv Dhir3, Goundappa K Balasubramani4, Wei Chen1, Chandler N Hudson1, Pooja Srivastava3, Anthony Green3, Donald B DeFranco5,6, Naoki Yoshimura1,6, Zhou Wang1,2,6.   

Abstract

INTRODUCTION AND
OBJECTIVE: Benign prostatic hyperplasia (BPH) is an age-related disease that is frequently associated with chronic prostatic inflammation. In previous studies, we detected the presence of PSA protein in the stroma of BPH nodules and down-regulation of junction proteins E-cadherin and claudin-1. Transmission electron microscopy (TEM) imaging showed a decrease in tight junctions suggesting the luminal epithelial barrier in BPH tissues may be compromised. Recent in vitro studies showed that stimulation of benign prostate epithelial cell lines with TGF-β1 induced a decrease in claudin-1 expression suggesting that inflammation might be associated with alterations in the prostate epithelial barrier. This study explored the potential associations between aging and loss of junction proteins and the presence of inflammatory cells in prostate tissue specimens from young healthy donors and aged BPH patients.
METHODS: Immunostaining of serial prostate sections from 13 BPH patients and five healthy young donors was performed for claudin-1, CD4, CD8, CD20 and CD68. H-Scores and the number of inflammatory cells were calculated for the same area in donor, normal adjacent prostate (NAP) to and BPH specimens. Quantification and statistical correlation analyses were performed.
RESULTS: Claudin-1 immunostaining was inversely associated with increasing age, and inflammation in prostate specimens. B-cell infiltration increased with age and BPH was associated with an increased infiltration of T-cells and macrophages compared to NAP.
CONCLUSIONS: These findings suggest that aging is associated with down-regulation of claudin-1 and claudin-1 is further decreased in BPH. Claudin-1 down-regulation was associated with increased infiltration of inflammatory cells in both NAP and BPH tissues. Claudin-1 down-regulation in the aging prostate could contribute to increased prostatic inflammation, subsequently contributing to BPH pathogenesis. AJCEU
Copyright © 2021.

Entities:  

Keywords:  BPH; Claudin-1; aging; inflammation; prostate

Year:  2021        PMID: 33816694      PMCID: PMC8012836     

Source DB:  PubMed          Journal:  Am J Clin Exp Urol        ISSN: 2330-1910


  40 in total

Review 1.  Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action.

Authors:  Karl-Erik Andersson; William C de Groat; Kevin T McVary; Tom F Lue; Mario Maggi; Claus G Roehrborn; Jean Jacques Wyndaele; Thomas Melby; Lars Viktrup
Journal:  Neurourol Urodyn       Date:  2011-01-31       Impact factor: 2.696

2.  Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.

Authors:  So Inamura; Tomochika Shinagawa; Hitomi Hoshino; Yasuhiro Sakai; Yoshiaki Imamura; Osamu Yokoyama; Motohiro Kobayashi
Journal:  Prostate       Date:  2017-02-09       Impact factor: 4.104

3.  Upregulation of androgen-responsive genes and transforming growth factor-β1 cascade genes in a rat model of non-bacterial prostatic inflammation.

Authors:  Yasuhito Funahashi; Katherine J O'Malley; Naoki Kawamorita; Pradeep Tyagi; Donald B DeFranco; Ryosuke Takahashi; Momokazu Gotoh; Zhou Wang; Naoki Yoshimura
Journal:  Prostate       Date:  2013-12-17       Impact factor: 4.104

4.  Age, height, BMI and FBG predict prostate volume in ageing benign prostatic hyperplasia: Evidence from 5285 patients.

Authors:  Jialin Meng; Yi Liu; Shi-Yang Guan; Huiya Ma; Xiaoyu Zhang; Song Fan; Huaqing Hu; Meng Zhang; Chaozhao Liang
Journal:  Int J Clin Pract       Date:  2019-10-21       Impact factor: 2.503

Review 5.  Prostatic fibrosis, lower urinary tract symptoms, and BPH.

Authors:  Jose A Rodriguez-Nieves; Jill A Macoska
Journal:  Nat Rev Urol       Date:  2013-07-16       Impact factor: 14.432

Review 6.  Inflammatory mediators in the development and progression of benign prostatic hyperplasia.

Authors:  Cosimo De Nunzio; Fabrizio Presicce; Andrea Tubaro
Journal:  Nat Rev Urol       Date:  2016-09-30       Impact factor: 14.432

Review 7.  Etiology and disease process of benign prostatic hyperplasia.

Authors:  J T Isaacs; D S Coffey
Journal:  Prostate Suppl       Date:  1989

8.  The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males.

Authors:  Yang Xiong; Yangchang Zhang; Xiaoyu Li; Feng Qin; Jiuhong Yuan
Journal:  Aging Male       Date:  2020-06-25       Impact factor: 5.892

Review 9.  Epidemiology of clinical benign prostatic hyperplasia.

Authors:  Kok Bin Lim
Journal:  Asian J Urol       Date:  2017-06-09
View more
  2 in total

1.  Increased COX-1 expression in benign prostate epithelial cells is triggered by mitochondrial dysfunction.

Authors:  Chandler N Hudson; Kai He; Laura E Pascal; Teresa Liu; Livianna K Myklebust; Rajiv Dhir; Pooja Srivastava; Naoki Yoshimura; Zhou Wang; William A Ricke; Donald B DeFranco
Journal:  Am J Clin Exp Urol       Date:  2022-08-15

2.  E-cadherin deficiency promotes prostate macrophage inflammation and bladder overactivity in aged male mice.

Authors:  Laura E Pascal; Taro Igarashi; Shinsuke Mizoguchi; Wei Chen; Lora H Rigatti; Caroline G Madigan; Rajiv Dhir; Wade Bushman; Donald B DeFranco; Naoki Yoshimura; Zhou Wang
Journal:  Aging (Albany NY)       Date:  2022-03-31       Impact factor: 5.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.